Concert Pharmaceuticals
Pharmaceuticals, 65 Hayden Ave, Lexington, Massachusetts, 02421, United States, 51-200 Employees
Phone Number: 78********
Who is CONCERT PHARMACEUTICALS
Concert Pharmaceuticals is a clinical stage biopharmaceutical company that is developing small molecule drugs that it discovered through the application of its DCE Platform (deuterated ch...
Read More
-
Headquarters: 65 Hayden Ave, Lexington, Massachusetts, 02421, United States
-
Date Founded: 2006
-
Employees: 51-200
-
Revenue: $25 Million to $50 Million
-
Active Tech Stack: See technologies
Industry: Pharmaceuticals
SIC Code: 2834
|
NAICS Code: 325412 |
Show More
Does something look wrong? Fix it. | View contact records from CONCERT PHARMACEUTICALS
Concert Pharmaceuticals Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Concert Pharmaceuticals
Answer: Concert Pharmaceuticals's headquarters are located at 65 Hayden Ave, Lexington, Massachusetts, 02421, United States
Answer: Concert Pharmaceuticals's phone number is 78********
Answer: Concert Pharmaceuticals's official website is https://concertpharma.com
Answer: Concert Pharmaceuticals's revenue is $25 Million to $50 Million
Answer: Concert Pharmaceuticals's SIC: 2834
Answer: Concert Pharmaceuticals's NAICS: 325412
Answer: Concert Pharmaceuticals has 51-200 employees
Answer: Concert Pharmaceuticals is in Pharmaceuticals
Answer: Concert Pharmaceuticals contact info: Phone number: 78******** Website: https://concertpharma.com
Answer: Concert Pharmaceuticals is a clinical stage biopharmaceutical company that is developing small molecule drugs that it discovered through the application of its DCE Platform (deuterated chemical entity platform). Selective incorporation of deuterium into known molecules has the potential, on a case-by-case basis, to provide better pharmacokinetic or metabolic properties, thereby enhancing their clinical safety, tolerability or efficacy. Concerts lead product candidate is in late-stage development for the treatment of alopecia areata, a serious autoimmune dermatological condition. Concert is also assessing a number of earlier-stage pipeline candidates
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month